首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Cyclic GMP sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye
【2h】

Cyclic GMP sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye

机译:循环GMP硝普钠和叠氮化钠可减少离体动脉灌注猪眼的房水形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The effect of nitric oxide (NO) on aqueous humour formation (AHF) and intraocular pressure (IOP) was studied using NO donors, sodium azide (AZ) and sodium nitroprusside (SNP).Using the porcine arterially perfused eye preparation, drug effects on AHF and IOP were measured by fluorescein dilution and manometry, respectively. Perfusion pressure of the ocular vasculature was also monitored using digital pressure transducer and pen recorder.L-Arginine (1.0 mM), a precursor of NO, but not D-arginine (1.0 mM), the inactive analogue, produced a significant reduction in AHF (28.5%) and IOP (21.1%). L-NAME (L-nitro-L-arginine) (10–100 μM), an NO synthase inhibitor, had no effect on AHF and IOP. However, L-NAME (100 μM) completely reversed L-arginine's effect.AZ and SNP reduced the AHF and IOP dose-dependently. AZ at 100 nM, 1 and 10 μM reduced AHF by 26.0, 39.7 and 51.7% and IOP by 10.8, 17.3 and 24.0%, respectively. SNP at 1, 10 and 100 μM reduced the AHF by 6.0, 24.2 and 35.4% and IOP by 3.5, 9.5 and 15.5%, respectively. 8-pCPT-cGMP (8-para-chlorophenyl-thioguanosine-3′,5′-cyclic guanosine monophosphate, 10 μM), a cGMP analogue, also reduced the AHF (34.9%) and IOP (15.9%).The effects of AZ and SNP on the AHF and IOP were blocked by a soluble guanylate cyclase inhibitor ODQ (10 μM), whereas ODQ alone or combined with 8-pCPT-cGMP had no effect on the AHF and IOP.None of the drugs had any significant effect on ocular vasculature.The reduction of the AHF and IOP in the arterially perfused pig eye by nitrovasodilators is likely to involve the NO-cGMP pathway.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 使用NO供体,叠氮化钠(AZ)和硝普钠(SNP)研究了一氧化氮(NO)对房水形成(AHF)和眼内压(IOP)的影响。 使用猪动脉灌注的眼睛制剂,分别通过荧光素稀释和测压法测量对AHF和IOP的药物作用。还使用数字压力传感器和笔记录器监测眼部脉管系统的灌注压力。 L-精氨酸(1.0 mM),NO的前体,但非D-精氨酸(1.0 mM),无活性的类似物,导致AHF(28.5%)和IOP(21.1%)显着降低。 NO合酶抑制剂L-NAME(L-硝基-L-精氨酸)(10–100μM)对AHF和IOP没有影响。然而,L-NAME(100μm)完全逆转了L-精氨酸的作用。 AZ和SNP剂量依赖性地降低了AHF和IOP。 100 nM,1和101μM的AZ使AHF分别降低26.0、39.7和51.7%,IOP分别降低10.8、17.3和24.0%。 1、10和100μm的SNP分别使AHF降低了6.0、24.2和35.4%,IOP降低了3.5、9.5和15.5%。 cGMP类似物8-pCPT-cGMP(8-对氯苯基-硫代鸟苷-3',5'-环鸟苷一磷酸,10μm)也降低了AHF(34.9%)和IOP(15.9%)。 可溶的鸟苷酸环化酶抑制剂ODQ(10μm)阻断了AZ和SNP对AHF和IOP的作用,而单独使用ODQ或与8-pCPT-cGMP联合使用对AZ和SNP的作用均不起作用。 / li> 没有一种药物对眼部血管具有显着影响。 硝化血管扩张剂降低了动脉灌注猪眼的AHF和IOP可能与NO-cGMP途径有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号